Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:ARDT NASDAQ:CELC NASDAQ:LFST NASDAQ:SBC On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeARDTArdent Health$12.64+1.2%$12.46$10.10▼$20.72$1.81BN/A404,972 shs112,734 shsCELCCelcuity$50.86-1.8%$22.44$7.57▼$53.85$1.98B0.68577,733 shs375,301 shsLFSTLifeStance Health Group$5.49+0.8%$4.69$3.74▼$8.61$2.13B1.132.00 million shs1.04 million shsSBCSBC Medical Group$4.36-2.4%$4.64$2.62▼$19.50$451.22M1.2767,984 shs45,612 shsThe 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceARDTArdent Health0.00%+5.14%+11.93%-17.30%-26.33%CELCCelcuity0.00%+12.88%+281.09%+384.47%+212.93%LFSTLifeStance Health Group0.00%+24.49%+28.91%-6.85%-3.72%SBCSBC Medical Group0.00%+1.36%-21.06%+30.79%+445,999,900.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationARDTArdent Health3.2428 of 5 stars3.40.00.00.02.40.03.1CELCCelcuity1.1104 of 5 stars1.52.00.00.02.83.30.0LFSTLifeStance Health Group3.2338 of 5 stars3.44.00.00.02.72.50.6SBCSBC Medical GroupN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceARDTArdent Health 2.70Moderate Buy$19.5654.81% UpsideCELCCelcuity 3.00Buy$50.60-0.50% DownsideLFSTLifeStance Health Group 2.86Moderate Buy$8.5054.97% UpsideSBCSBC Medical Group 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest SBC, CELC, ARDT, and LFST Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/18/2025CELCCelcuityHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$50.00 ➝ $66.008/15/2025CELCCelcuityNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$74.00 ➝ $70.008/11/2025ARDTArdent HealthJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$18.00 ➝ $15.008/8/2025LFSTLifeStance Health GroupUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$8.50 ➝ $9.008/7/2025ARDTArdent HealthKeyCorpSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$24.00 ➝ $20.007/28/2025CELCCelcuityLeerink PartnersSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$28.00 ➝ $60.007/28/2025CELCCelcuityHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$27.00 ➝ $50.007/28/2025CELCCelcuityNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$29.007/25/2025LFSTLifeStance Health GroupBTIG ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$8.007/16/2025ARDTArdent HealthBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeNeutral ➝ Underperform$15.50 ➝ $14.607/1/2025CELCCelcuityStifel NicolausSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$30.00(Data available from 8/18/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookARDTArdent Health$5.97B0.30$2.57 per share4.92$10.66 per share1.19CELCCelcuityN/AN/AN/AN/A$3.11 per shareN/ALFSTLifeStance Health Group$1.25B1.71$0.04 per share137.19$3.78 per share1.45SBCSBC Medical Group$205.42M2.20$0.59 per share7.35$1.90 per share2.29Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateARDTArdent Health$210.34M$1.816.986.455.524.11%16.66%5.18%11/5/2025 (Estimated)CELCCelcuity-$111.78M-$3.45N/AN/AN/AN/A-126.74%-60.59%N/ALFSTLifeStance Health Group-$57.44M-$0.05N/AN/AN/A-1.23%-1.11%-0.76%11/6/2025 (Estimated)SBCSBC Medical Group$46.61M$0.3213.610.77N/A17.71%20.76%15.56%N/ALatest SBC, CELC, ARDT, and LFST EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/14/2025Q2 2025CELCCelcuity-$0.90-$1.04-$0.14-$1.04N/AN/A8/13/2025Q2 2025SBCSBC Medical Group$0.14$0.02-$0.12$0.02$44.71 million$43.36 million8/7/2025Q2 2025LFSTLifeStance Health Group-$0.03-$0.01+$0.02-$0.01$345.05 million$345.31 million8/5/2025Q2 2025ARDTArdent Health$0.30$0.52+$0.22$0.52$1.54 billion$1.65 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthARDTArdent HealthN/AN/AN/AN/AN/ACELCCelcuityN/AN/AN/AN/AN/ALFSTLifeStance Health GroupN/AN/AN/AN/AN/ASBCSBC Medical GroupN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioARDTArdent Health0.662.132.00CELCCelcuity1.146.616.61LFSTLifeStance Health Group0.191.481.48SBCSBC Medical Group0.033.983.95Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipARDTArdent HealthN/ACELCCelcuity63.33%LFSTLifeStance Health Group85.50%SBCSBC Medical Group60.82%Insider OwnershipCompanyInsider OwnershipARDTArdent Health1.70%CELCCelcuity15.78%LFSTLifeStance Health Group6.60%SBCSBC Medical Group89.47%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableARDTArdent Health24,900143.11 million140.67 millionOptionableCELCCelcuity4038.91 million32.77 millionOptionableLFSTLifeStance Health Group10,218388.94 million363.27 millionOptionableSBCSBC Medical GroupN/A103.61 million10.91 millionN/ASBC, CELC, ARDT, and LFST HeadlinesRecent News About These CompaniesSBC Medical Group (NASDAQ:SBC) Downgraded to "Buy" Rating by Wall Street ZenAugust 18 at 2:33 AM | americanbankingnews.comSBC Medical Group (NASDAQ:SBC) Releases Earnings Results, Misses Estimates By $0.12 EPSAugust 17 at 2:53 PM | marketbeat.comSBC Medical Group (NASDAQ:SBC) Rating Lowered to "Buy" at Wall Street ZenAugust 17 at 2:36 AM | marketbeat.comSBC Medical Group Holdings Second Quarter 2025 Earnings: EPS: US$0.024 (vs US$0.20 in 2Q 2024)August 15 at 9:17 PM | finance.yahoo.comSBC Medical Group reports Q2 EPS 2c vs. 20c last yearAugust 13, 2025 | msn.comINSERTING and REPLACING SBC Medical Group Holdings Announces Second Quarter 2025 Financial ResultsAugust 13, 2025 | businesswire.comSbc Medical Group Posts Weak Fiscal Q2August 13, 2025 | theglobeandmail.comSBC Medical Group Holdings Announces Second Quarter 2025 Financial ResultsAugust 13, 2025 | finance.yahoo.comSBC Medical Group (SBC) Projected to Post Quarterly Earnings on WednesdayAugust 7, 2025 | marketbeat.comSBC Medical Group (NASDAQ:SBC) Stock Price Down 1.2% - Here's WhyJuly 24, 2025 | marketbeat.comSBC: Recent Growth Initiatives, Takeaways Regarding 2Q25 / 2025July 23, 2025 | finance.yahoo.comSBC Medical Group (NASDAQ:SBC) Sees Large Volume Increase - Here's What HappenedJuly 21, 2025 | marketbeat.comSBC Medical Group (NASDAQ:SBC) Trading Down 4% - Should You Sell?July 19, 2025 | marketbeat.comSBC Medical Group (NASDAQ:SBC) Shares Gap Down - Should You Sell?July 18, 2025 | marketbeat.comSBC Medical Group Acquires MB Career Lounge: "JUN CLINIC" Joins the Group, Strengthening Competitive Position in a Growing MarketJuly 17, 2025 | finance.yahoo.comSBC Medical Appoints Dr. Steven R. Cohen as Medical Strategy Advisor to Accelerate Global ExpansionJuly 15, 2025 | joplinglobe.comJSBC Medical Appoints Dr. Steven R. Cohen as Medical Strategy Advisor to Accelerate Global ExpansionJuly 14, 2025 | businesswire.comSBC Stock Price Quote - MorningstarJuly 13, 2025 | morningstar.comMReturns on Capital Paint A Bright Future For SBC Medical Group Holdings (NASDAQ:SBC)July 8, 2025 | finance.yahoo.comSBC Medical Appoints New Chief Marketing Officer to Enhance Marketing Infrastructure and Strengthen Brand Power - Seeking AlphaJuly 3, 2025 | seekingalpha.comSBC Medical Appoints New Chief Marketing Officer to Enhance Marketing Infrastructure and Strengthen Brand PowerJuly 1, 2025 | globenewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeSBC, CELC, ARDT, and LFST Company DescriptionsArdent Health NYSE:ARDT$12.64 +0.16 (+1.24%) As of 02:56 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Ardent Health Partners, Inc. owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee. Ardent Health Partners, Inc. is a subsidiary of EGI-AM Investments, L.L.C.Celcuity NASDAQ:CELC$50.86 -0.94 (-1.81%) As of 02:57 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Celcuity Inc., a clinical stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therapy for the treatment. Its drug candidate includes Gedatolisib, which selectively targets various class I isoforms of PI3K and mammalian target of rapamycin and focus on the treatment of patients with hormone receptor positive, HER2-negative, advanced or metastatic breast cancer, and metastatic castration resistant prostate cancer. It had a license agreement with Pfizer, Inc. for the development and commercialization rights to Gedatolisib. The company was founded in 2011 and is headquartered in Minneapolis, Minnesota.LifeStance Health Group NASDAQ:LFST$5.48 +0.05 (+0.83%) As of 02:57 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates an outpatient mental health platform, as well as offers patient care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was founded in 2017 and is headquartered in Scottsdale, Arizona.SBC Medical Group NASDAQ:SBC$4.36 -0.11 (-2.35%) As of 02:54 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.SBC Medical Group Holdings Incorporated, through its subsidiaries, provides services to support the operation of clinics which deliver specialized medical services in the areas of cosmetic medicine, esthetic dentistry and Androgenetic Alopecia or AGA, primarily in Japan and centered on the SBC Shonan Beauty Clinic Brand. SBC Medical Group Holdings Incorporated, formerly known as Pono Capital Two Inc., is based in TOKYO. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Is Whirlpool A Screamin’ Buy in 2025? Signs Say Yes Applied Materials' Knee-Jerk Sell-Off Is Your Signal to Buy Is Reddit Stock Too Hot, or Just Right? Buffett’s Mystery Buy Revealed, and It’s a Big Bet on UNH AI Glasses to Replace Smartphones? Meta Is Taking Aim at Apple Why Arista's Blowout Q2 Is Good News for Chip-Giant Broadcom Deere’s Sell-Off Could Be a Long-Term Buying Chance 3 Restaurant Stocks That Will Outperform in Q3 and Q4 Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.